Lexicon Pharmaceuticals I... (LXRX)
0.73
0.04 (5.51%)
At close: Jan 15, 2025, 3:50 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 |
| Net Income | -177.12M | -101.94M | -87.76M | -58.57M | 130.13M | -120.55M | -129.05M | -141.43M | -4.68M | -100.29M | -104.13M | -110.21M | -116.22M | -101.78M | -93.32M | -76.86M | -58.79M | -54.31M | -36.31M | -47.17M | -64.20M | -59.67M | -35.17M | -25.99M | -12.50M |
| Depreciation & Amortization | 554.00K | 427.00K | 292.00K | 2.93M | 3.65M | 3.68M | 3.40M | 2.06M | 727.00K | 1.93M | 2.86M | 4.19M | 4.89M | 5.39M | 6.16M | 10.07M | 10.42M | 11.20M | 11.63M | 12.87M | 21.53M | 20.58M | 16.55M | 2.62M | 2.00M |
| Stock-Based Compensation | 14.34M | 11.52M | 10.58M | 13.27M | 14.22M | 11.70M | 9.47M | 7.45M | 6.84M | 7.08M | 7.42M | 6.50M | 5.71M | 5.48M | 5.27M | 6.50M | 7.93M | 7.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | -2.43M | 340.00K | 3.55M | -1.52M | -28.21M | -22.09M | -50.30M | -73.34M | 171.35M | 697.00K | -438.00K | -293.00K | -152.00K | 6.25M | -5.74M | -14.34M | -24.06M | -22.54M | 48.11M | -7.95M | 31.89M | 10.10M | 632.00K | 1.03M | 900.00K |
| Other Non-Cash Items | -2.33M | 744.00K | 54.00K | -131.57M | 30.10M | 1.34M | 2.70M | -176.00K | 6.45M | 13.44M | -2.21M | 9.89M | -109.45M | 2.71M | -1.17M | 7.81M | 7.93M | 7.03M | 10.00K | -11.00K | 3.06M | 197.00K | n/a | 20.84M | n/a |
| Deferred Income Tax | n/a | n/a | 49.00K | -110.00K | -6.01M | n/a | -12.66M | 16.00K | 3.55M | -70.00K | n/a | n/a | 116.92M | 4.82M | 2.58M | -26.52M | -20.36M | -7.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 2.66M | 402.00K | -10.23M | 31.08M | -58.29M | -44.77M | -59.26M | -43.55M | 171.89M | 2.29M | 4.97M | -4.82M | 10.21M | 1.01M | -8.54M | -16.60M | -21.44M | -20.86M | 48.11M | -7.95M | 31.89M | 10.10M | 632.00K | 1.03M | 900.00K |
| Operating Cash Flow | -161.90M | -88.85M | -87.02M | -142.97M | 113.81M | -148.61M | -185.39M | -175.63M | 184.78M | -75.62M | -91.08M | -94.46M | -87.94M | -82.37M | -89.02M | -95.60M | -74.32M | -56.91M | 23.44M | -42.26M | -7.72M | -28.79M | -17.99M | -1.50M | -9.60M |
| Capital Expenditures | -470.00K | -1.33M | -1.22M | -87.00K | -70.00K | -95.00K | -228.00K | -231.00K | -910.00K | -80.00K | -1.72M | -492.00K | -1.21M | -1.13M | -369.00K | -2.19M | -1.90M | -3.58M | -11.28M | -11.81M | -4.82M | -19.77M | -13.47M | -7.71M | -4.10M |
| Acquisitions | n/a | 69.75M | -3.33M | 11.01M | 155.78M | n/a | n/a | n/a | 335.00K | n/a | n/a | n/a | n/a | -5.56M | n/a | -20.06M | n/a | n/a | n/a | 91.00K | 48.00K | n/a | n/a | n/a | n/a |
| Purchase of Investments | -223.34M | -133.95M | -34.26M | -58.55M | -322.38M | -119.99M | -267.87M | -425.67M | -326.45M | -221.95M | -111.49M | -233.25M | -108.09M | -155.86M | -64.20M | -39.85M | -305.73M | -67.69M | -175.24M | -178.35M | -33.31M | -91.96M | -366.70M | -269.85M | -12.50M |
| Sales Maturities Of Investments | 173.87M | 64.20M | 37.59M | 268.00M | 166.60M | 289.66M | 318.62M | 444.16M | 210.00M | 111.44M | 212.63M | 135.85M | 176.63M | 48.64M | 76.34M | 201.45M | 119.68M | 95.68M | 170.40M | 216.18M | 65.44M | 181.75M | 387.35M | 112.11M | 21.80M |
| Other Investing Acitivies | n/a | -69.75M | 3.33M | 160.38M | -155.78M | 169.67M | 50.75M | 18.48M | 335.00K | 2.17M | 130.00K | 85.00K | 2.63M | 64.00K | 107.00K | 20.06M | 1K | 56.00K | 123.00K | 14.37M | -27.48M | -22.79M | -752.00K | n/a | n/a |
| Investing Cash Flow | -49.94M | -71.08M | 2.11M | 380.76M | -155.85M | 169.58M | 50.52M | 18.25M | -117.02M | -108.42M | 99.54M | -97.81M | 69.95M | -113.84M | 11.88M | 159.41M | -187.95M | 24.46M | -15.99M | 40.48M | -128.00K | 47.23M | 6.42M | -165.45M | 5.20M |
| Debt Repayment | 49.96M | 48.87M | -11.70M | -216.58M | -1.28M | -2.00M | 143.63M | -2.02M | -1.86M | 82.42M | -1.57M | -1.44M | -3.59M | -38.48M | 36.47M | -881.00K | -815.00K | -751.00K | -691.00K | -18.71M | n/a | 4.00M | -3.91M | -1.59M | 3.50M |
| Common Stock Repurchased | -824.00K | -864.00K | -2.67M | -1.03M | -941.00K | -972.00K | -1.68M | -621.00K | -357.00K | -887.00K | -873.00K | -285.00K | -108.00K | -149.00K | -88.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 70.00K | n/a | -26.00K | n/a | n/a | n/a | n/a | n/a | 42.71M | n/a | n/a | -2.47M | n/a | n/a | n/a | n/a | n/a |
| Financial Cash Flow | 187.96M | 142.21M | 22.71M | -147.64M | -2.23M | -2.24M | 149.93M | 987.00K | -2.03M | 283.81M | -1.39M | 36.38M | 157.08M | 142.87M | 91.82M | -880.00K | 254.99M | 40.70M | -95.00K | -19.47M | 50.40M | 4.57M | -3.19M | 202.73M | 3.40M |
| Net Cash Flow | -23.88M | -17.72M | -62.20M | 90.15M | -44.27M | 18.73M | 15.06M | -156.39M | 65.72M | 99.77M | 7.08M | -155.89M | 139.10M | -53.35M | 14.68M | 62.94M | -7.29M | 8.26M | 7.36M | -21.24M | 42.55M | 23.01M | -14.76M | 35.79M | -1.00M |
| Free Cash Flow | -162.37M | -90.18M | -88.24M | -143.06M | 113.74M | -148.70M | -185.62M | -175.86M | 183.87M | -75.70M | -92.80M | -94.95M | -89.14M | -83.50M | -89.39M | -97.79M | -76.22M | -60.49M | 12.16M | -54.07M | -12.54M | -48.56M | -31.46M | -9.21M | -13.70M |